IP Library Granted Patent US 10,443,098
Granted Patent B2
US 10,443,098 · App. 15/677,870 · Granted Oct 15, 2019

Method and system for sequencing nucleic acids

Inventors: Kandaswamy Vijayan (San Diego, CA); Corey M. Dambacher (La Jolla, CA); Eugene Tu (San Diego, CA); Mark A. Bernard (Poway, CA); Joseph Rokicki (San Diego, CA); Kerry Wilson (La Jolla, CA)
Assignee: OMNIOME, INC.
C12Q1/6869C12N15/1068C12P19/34C12Q1/6874G01N33/50C12Q2521/101
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,443,098
App. No.
15/677,870
Granted
Oct 15, 2019
Kind
B2
Abstract

Provided are compositions, methods and systems for determining the sequence of a template nucleic acid using a polymerase-based, sequencing-by-binding procedure. An examination step involves monitoring the interaction between a polymerase and template nucleic acid in the presence of one or more nucleotides. Identity of the next correct nucleotide in the sequence is determined without incorporation of any nucleotide into the structure of the primer by formation of a phosphodiester bond. An optional incorporation step can be used after the examination step to extend the primer by one or more nucleotides, thereby incrementing the template nucleotides that can be examined in a subsequent examination step. The sequencing-by-binding procedure does not require the use of labeled nucleotides or polymerases, but optionally can employ these reagents.

Claims (30)

1. A method of identifying a template base in a primed template nucleic acid, the method comprising:

(a) contacting a primed template nucleic acid with a polymerase and nucleotides that complement four different types of bases in the template nucleic acid, under conditions that stabilize a first ternary complex at a template base, the first ternary complex comprising the primed template nucleic acid, polymerase and a cognate nucleotide for the template base;

(b) detecting the first ternary complex while precluding incorporation of any nucleotide into the primer;

(c) removing the polymerase and the cognate nucleotide from the primed template nucleic acid;

(d) contacting the primed template nucleic acid from step (c) with a polymerase and nucleotides that complement four different types of bases in the template nucleic acid, under conditions that stabilize a second ternary complex at the template base, the second ternary complex comprising the primed template nucleic acid, polymerase and a cognate for the template base nucleotide;

(e) detecting the second ternary complex while precluding incorporation of any nucleotide into the primer; and

(f) identifying the template base from the first ternary complex and the second ternary complex.

2. The method of claim 1 , wherein the first and second ternary complexes are stabilized by the presence of a reversible terminator moiety on the 3′ terminal nucleotide of the primer.

3. The method of claim 2 , further comprising, after step (d), removing the reversible terminator moiety on the 3′ terminal nucleotide of the primer.

4. The method of claim 1 , wherein each of the cognate nucleotides is an unlabeled nucleotide.

5. The method of claim 1 , wherein the polymerases comprise exogenous labels that are detected.

6. The method of claim 1 , wherein the cognate nucleotides comprise exogenous labels that are detected.

7. The method of claim 1 , further comprising (g) incorporating a nucleotide at the 3′ end of the primer after step (e), thereby producing an extended primed template nucleic acid.

8. The method of claim 7 , wherein the nucleotide that is incorporated is an unlabeled nucleotide.

9. The method of claim 8 , wherein the nucleotide that is incorporated is an unlabeled reversible terminator nucleotide.

10. The method of claim 7 , further comprising repeating steps (a) through (g) using the extended primed template nucleic acid in place of the primed template nucleic acid, thereby sequencing the template nucleic acid.

11. A method of sequencing a template nucleic acid, comprising:

(a) contacting a primed template nucleic acid with a polymerase and a first combination of nucleotides that complement four different types of bases in the template nucleic acid, under conditions that form a stabilized ternary complex between the polymerase, primed template nucleic acid and a nucleotide that is complementary to a next base of the primed template nucleic acid;

(b) detecting the ternary complex while precluding incorporation of nucleotides into the primer;

(c) repeating steps (a) and (b) using the primed template nucleic acid, a polymerase and a second combination of nucleotides that complement four different types of bases in the template nucleic acid, thereby forming and examining a second ternary complex at the next base of the primed template nucleic acid;

(d) incorporating into the primer, after step (c), a nucleotide that is complementary to the next base, thereby producing an extended primed template nucleic acid; and

(e) repeating steps (a) through (d) using the extended primed template nucleic acid in place of the primed template nucleic acid, thereby sequencing the primed template nucleic acid.

12. The method of claim 11 , further comprising removing the polymerase and next correct nucleotide from the primed template nucleic acid prior to repeating steps (a) and (b).

13. The method of claim 11 , wherein the ternary complex is stabilized by the presence of a reversible terminator moiety on the 3′ terminal nucleotide of the primer.

14. The method of claim 13 , further comprising, after step (c), removing the reversible terminator moiety on the 3′ terminal nucleotide of the primer.

15. The method of claim 11 , wherein the nucleotide that is complementary to the next base of the primed template nucleic acid is an unlabeled nucleotide.

16. The method of claim 11 , wherein the polymerase comprises an exogenous label that is detected in step (b).

17. The method of claim 11 , wherein the nucleotide that is complementary to the next base of the primed template nucleic acid comprises an exogenous label that is detected in step (b).

18. The method of claim 11 , wherein the nucleotide that is incorporated into the primer is an unlabeled nucleotide.

19. The method of claim 18 , wherein the nucleotide that is incorporated into the primer is an unlabeled reversible terminator nucleotide.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 28, 2022
From: OMNIOME, LLC
To: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Reel/Frame 058809/0072 →
MERGER AND CHANGE OF NAME Recorded Jan 27, 2022
From: OMNIOME, INC.; APOLLO ACQUISITION SUB, LLC
To: OMNIOME, LLC
Reel/Frame 058799/0661 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 19, 2017
From: VIJAYAN, KANDASWAMY; DAMBACHER, COREY M.; TU, EUGENE; BERNARD, MARK A.; ROKICKI, JOSEPH; WILSON, KERRY
To: OMNIOME, INC.
Reel/Frame 043903/0086 →
Continuity (3)
Provisional Application 62375379 · Aug 15, 2016
Provisional Application 62447319 · Jan 17, 2017
Related Publication 20180044727A1 · Feb 15, 2018
Cited By (5)
US 12,241,891 US 12,344,890 US 12,540,350 US 12,624,390 US 12,716,089